Home›Search›MedComm - Oncology

MedComm - Oncology

John Wiley and Sons Inc · China · Est. 2022

ISSN2769-6448eISSN2769-6448

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (2 more)+12

Total90

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

148

days submission → published

measured · last 19 articles · accept 108d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.502

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

174

Total Citationsi

958

2yr Mean Citednessi

4.58

Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Biochemistry, Genetics and Molecular Biology (miscellaneous); Cancer Research; Cell Biology.

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published2022

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications174

Publisher OrgWiley

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~15 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2769-6448 / 2769-6448

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2022

418

2023

519

2024

109

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

OncologyQ1

Cancer ResearchQ2

Cell BiologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Cancer ResearchOncologyCell Biology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Cells and MetastasisCancer, Hypoxia, and MetabolismCancer Research and TreatmentsEpigenetics and DNA MethylationNanoplatforms for cancer theranosticsProtein Degradation and InhibitorsCancer-related molecular mechanisms researchRNA modifications and cancerCAR-T cell therapy research

Frequently asked questions about MedComm - Oncology

Is MedComm - Oncology a predatory journal?

PubScope has no integrity flags on record for MedComm - Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of MedComm - Oncology?

MedComm - Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.58.

Is MedComm - Oncology indexed in Scopus and Web of Science?

MedComm - Oncology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of MedComm - Oncology?